Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

US And Canada

Corporates help Remiges close $95m fund
Taiho has reupped its commitment to the second fund of Remiges, which focuses on spinouts of Japanese universities.
SambaNova rams through $676m series D
The Stanford-linked artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2.
Daily deal net: April 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Vizgen visualises $37m series B
Vizgen co-founder David Walt, a professor at Harvard Medical School, has invested in the spinout as part of its series B round.
HawkEye 360 hooks $55m in series C
Esri helped Allied Minds' satellite constellation operator take its total funding to $155m in a round that will fund the launch of more satellites.
Battery Resourcers charges up with $20m
Orbia Ventures led a round for the battery production technology provider that emerged out of Worcester Polytechnic Institute.
Snorkel AI pipes in $35m
GV returned for a series B round that increased the overall funding for Stanford’s machine learning technology developer to $50m.
Carta Healthcare carves out series A funding
CU Health Innovation Fund has chipped into a $17.3m round for the healthcare data technology provider.

Other News

Daily deal net: April 12, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Paragon passes acquisition exam
University of British Columbia spinout Paragon Testing Enterprises has agreed to an acquisition by Prometric Canada Testing Services.
Daily deal net: April 9, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Ventus Therapeutics executes $100m series B
RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.
Metagenomi magnifies series A to $75m
UC Berkeley's DNA-editing technology spinout has raised $10m from RA Capital in addition to the $65m it pocketed in November.
Icosavax racks up $100m
RA Capital Management has led a series B round for the UW-linked vaccine developer, which had raised $51m in a series A 18 months ago.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Editorial: For the good of investors
As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
test reg

Login